Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced MelanomaGlobeNewsWire • 06/28/24
The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's WhyThe Motley Fool • 06/10/24
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual MeetingGlobeNewsWire • 05/23/24
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate UpdatesGlobeNewsWire • 05/09/24
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024GlobeNewsWire • 05/01/24
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual MeetingGlobeNewsWire • 04/24/24